The Linkage of Cytotoxic Drugs to Monoclonal Antibodies for the Treatment of Cancer

被引:50
作者
Pietersz, Geoffrey A. [1 ]
机构
[1] Univ Melbourne, Dept Pathol, Res Ctr Canc & Transplantat, Parkville, Vic 3052, Australia
关键词
D O I
10.1021/bc00002a001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:89 / 95
页数:7
相关论文
共 75 条
[1]   CYTO-TOXIC ACTIVITY OF DAUNORUBICIN OR VINDESIN CONJUGATED TO A MONOCLONAL-ANTIBODY ON CULTURED MCF-7 BREAST-CARCINOMA CELLS [J].
ABOUDPIRAK, E ;
LESUR, B ;
RAO, KSPB ;
BAURAIN, R ;
TROUET, A ;
SCHNEIDER, YJ .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (04) :641-648
[2]  
Arcamone F., 1981, DOXORUBICIN ANTICANC
[3]  
BAGSHAWE KD, 1989, 4 INT C MON ANT IMM
[4]   ANTI-ONCOFETAL PROTEINS FOR TARGETING CYTO-TOXIC DRUGS [J].
BELLESISLES, M ;
PAGE, M .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1981, 3 (01) :97-102
[5]   A CHLORAMBUCIL-ANTI-CEA CONJUGATE CYTO-TOXIC FOR HUMAN-COLON ADENOCARCINOMA CELLS-INVITRO [J].
BERNIER, LG ;
PAGE, M ;
GAUDREAULT, RC ;
JOLY, LP .
BRITISH JOURNAL OF CANCER, 1984, 49 (02) :245-246
[6]   CHEMOTHERAPY OF MURINE OVARIAN CARCINOMA BY METHOTREXATE-ANTIBODY CONJUGATES [J].
BURSTEIN, S ;
KNAPP, R .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (07) :950-952
[7]   PROTEASE-ACTIVATED PRODRUGS FOR CANCER-CHEMOTHERAPY [J].
CARL, PL ;
CHAKRAVARTY, PK ;
KATZENELLENBOGEN, JA ;
WEBER, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (04) :2224-2228
[8]   PROTEIN THIOLATION AND REVERSIBLE PROTEIN-PROTEIN CONJUGATION - N-SUCCINIMIDYL 3-(2-PYRIDYLDITHIO)PROPIONATE, A NEW HETEROBIFUNCTIONAL REAGENT [J].
CARLSSON, J ;
DREVIN, H ;
AXEN, R .
BIOCHEMICAL JOURNAL, 1978, 173 (03) :723-737
[9]  
CASSADY JM, 1980, ANTICANCER AGENTS BA, V16
[10]  
CORCORAN JW, 1975, ANTIBIOTICS, V111